Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
设计用于新型疫苗佐剂乳液的可持续角鲨烯类似物
基本信息
- 批准号:10370340
- 负责人:
- 金额:$ 78.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-16 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAntigensBiologicalBiomedical EngineeringBrazilCaliforniaCharacteristicsChemical EngineeringChemicalsDataDevelopmentDoseEmulsionsEngineeringEnvironmental Engineering technologyEvaluationEventFormulationGovernment-Sponsored ProgramsHumanImmune responseIn VitroIndustrializationInfectious Diseases ResearchInfluenzaInfluenza A Virus, H5N1 SubtypeIsopreneLiteratureLiverModificationMolecular WeightNorth CarolinaOilsOrganismPathway interactionsPharmacologic SubstancePlant ExtractsPlant SourcesPolymer ChemistryPolymersPreclinical TestingProductionProgram SustainabilityPropertyReagentRecombinantsReportingResearch InstituteRouteShapesSharkSourceSqualeneStructureStructure-Activity RelationshipSubunit VaccinesTechnologyTerpenesTestingTimeTriglyceridesUniversitiesVaccine AdjuvantVaccine ProductionVaccinesWaterWorkYeastsanalogbaseclinical developmentexperienceimmunogenicityimprovedin vivoin vivo Modelinnovationisoprenoidmonomermouse modelnovelnovel vaccinespandemic influenzaprogramsresearch clinical testingtechnology developmentvaccine efficacy
项目摘要
Project Summary
Global pandemic influenza vaccine production capacity is insufficient to meet the expected demand in the event
of a highly lethal influenza pandemic. Current H5N1 vaccines require high antigen doses (e.g. 90 μg) or are
combined with squalene-based oil-in-water emulsion adjuvants for enhanced and broadened immunogenicity
as well as antigen dose sparing. Squalene is a naturally occurring oligoisoprene (i.e. a very low molecular weight
polymer of isoprene) derived from shark liver, a source with sustainability concerns. Moreover, the biological
mechanisms of action of squalene are still not well understood and no systematic comparison of the adjuvant
activity of squalene emulsions compared to emulsions based on analog oligoisoprenes has been reported in the
literature. This proposal defines a program to develop the sustainable production of various oligoisoprene
analogues of squalene using bioengineered organisms and synthetic polymer chemistry. Selected structures will
then be formulated in oil-in-water emulsions and evaluated for physicochemical stability. Importantly, we
propose to identify structure-activity relationships (SAR) by employing squalene and oligoisoprene analogues in
in vitro human and in vivo mouse models in combination with an H5N1 influenza antigen. Moreover, the ability
to further enhance adjuvant activity by chemical modification to improve physicochemical properties of selected
oligoisoprene structures will be evaluated. The technology generated could be applicable to many other vaccines
that have need of emulsion-based adjuvants for antigen dose sparing or enhanced immune responses.
项目总结
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Formulated Phospholipids as Non-Canonical TLR4 Agonists.
- DOI:10.3390/pharmaceutics14122557
- 发表时间:2022-11-22
- 期刊:
- 影响因子:5.4
- 作者:Liang H;Lykins WR;Seydoux E;Guderian JA;Phan T;Fox CB;Orr MT
- 通讯作者:Orr MT
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer Polymerization.
- DOI:10.3390/polym15183831
- 发表时间:2023-09-20
- 期刊:
- 影响因子:5
- 作者:Hege CS;Stimpson A;Sefton J;Summers J;Henke H;Dundas AA;Phan T;Kinsey R;Guderian JA;Sivananthan SJ;Mohamath R;Lykins WR;Ramer-Denisoff G;Lin S;Fox CB;Irvine DJ
- 通讯作者:Irvine DJ
Kilo-Scale GMP Synthesis of Renewable Semisynthetic Vaccine-Grade Squalene.
可再生半合成疫苗级角鲨烯的公斤级 GMP 合成。
- DOI:10.1021/acs.oprd.3c00300
- 发表时间:2023
- 期刊:
- 影响因子:3.4
- 作者:Fisher,KarlJ;Shirtcliff,Laura;Buchanan,Greg;Thompson,AndrewW;Woolard,FrankX;LaMunyon,DonaldH;Marshall,JonathanL;Baranouskas,MayaB;Voelker,RodgerB;Lusk,JasonS;Wells,CharlesE;Mohamath,Raodoh;Kinsey,Robert;Lykins,WilliamR
- 通讯作者:Lykins,WilliamR
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions.
- DOI:10.1038/s41541-023-00608-y
- 发表时间:2023-02-16
- 期刊:
- 影响因子:9.2
- 作者:
- 通讯作者:
Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response.
扩大角鲨烯乳液生产工艺以增强全球流行病应对能力。
- DOI:10.3390/ph13080168
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Phan,Tony;Devine,Christian;Laursen,ErikD;Simpson,Adrian;Kahn,Aaron;Khandhar,AmitP;Mesite,Steven;Besse,Brad;Mabery,KenJ;Flanagan,ElizabethI;Fox,ChristopherB
- 通讯作者:Fox,ChristopherB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher B Fox其他文献
Key roles of adjuvants in modern vaccines
佐剂在现代疫苗中的关键作用
- DOI:
10.1038/nm.3409 - 发表时间:
2013-12-05 - 期刊:
- 影响因子:50.000
- 作者:
Steven G Reed;Mark T Orr;Christopher B Fox - 通讯作者:
Christopher B Fox
Christopher B Fox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher B Fox', 18)}}的其他基金
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
设计用于新型疫苗佐剂乳液的可持续角鲨烯类似物
- 批准号:
9541529 - 财政年份:2018
- 资助金额:
$ 78.61万 - 项目类别:
Nanoformulation of Synergistic TLR Ligands to Enhance Amebiasis Vaccine Efficacy
协同 TLR 配体纳米制剂增强阿米巴病疫苗功效
- 批准号:
8769515 - 财政年份:2014
- 资助金额:
$ 78.61万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of cancer-testis antigens on the signaling and biological activity of the malignant melanoma cells
癌睾丸抗原对恶性黑色素瘤细胞信号传导和生物活性的影响
- 批准号:
26860894 - 财政年份:2014
- 资助金额:
$ 78.61万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Molecular biological research for Periodontal pathogenic surface antigens of Campylobacter rectus.
直肠弯曲杆菌牙周病原表面抗原的分子生物学研究。
- 批准号:
13671913 - 财政年份:2001
- 资助金额:
$ 78.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chlamydia pneumoniae Antigens of Biological Significance
具有生物学意义的肺炎衣原体抗原
- 批准号:
7026454 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
具有生物学意义的肺炎衣原体抗原
- 批准号:
2637348 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
具有生物学意义的肺炎衣原体抗原
- 批准号:
2887732 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
Elucidation for biological significance of cancer-associated carbohydrate antigens through genetic modification of carbohydrates
通过碳水化合物的基因修饰阐明癌症相关碳水化合物抗原的生物学意义
- 批准号:
10671215 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chlamydia pneumoniae Antigens of Biological Significance
具有生物学意义的肺炎衣原体抗原
- 批准号:
6624069 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
Chlamydia pneumoniae Antigens of Biological Significance
具有生物学意义的肺炎衣原体抗原
- 批准号:
6877105 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
CHLAMYDIA PNEUMONIAE ANTIGENS OF BIOLOGICAL SIGNIFICANCE
具有生物学意义的肺炎衣原体抗原
- 批准号:
6170907 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别:
Chlamydia pneumoniae Antigens of Biological Significance
具有生物学意义的肺炎衣原体抗原
- 批准号:
6472104 - 财政年份:1998
- 资助金额:
$ 78.61万 - 项目类别: